PT98842A - Processo para a preparacao de derivados de fenilalanina e de fenetilamina n-substituidos com cicloalquilo e policicloalquilo, alfa-substituidos com arilo e heteroarilo e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de derivados de fenilalanina e de fenetilamina n-substituidos com cicloalquilo e policicloalquilo, alfa-substituidos com arilo e heteroarilo e de composicoes farmaceuticas que os contem

Info

Publication number
PT98842A
PT98842A PT98842A PT9884291A PT98842A PT 98842 A PT98842 A PT 98842A PT 98842 A PT98842 A PT 98842A PT 9884291 A PT9884291 A PT 9884291A PT 98842 A PT98842 A PT 98842A
Authority
PT
Portugal
Prior art keywords
substituted
polycycloalquil
phyethylamine
phenylalanyl
heteroaryl
Prior art date
Application number
PT98842A
Other languages
English (en)
Other versions
PT98842B (pt
Inventor
David Christopher Herwell
David Charles Rees
Reginald Stewart Richardsen
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PT98842A publication Critical patent/PT98842A/pt
Publication of PT98842B publication Critical patent/PT98842B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06156—Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Addiction (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT98842A 1990-08-31 1991-08-30 Processo para a preparacao de derivados de fenilalanina e de fenetilamina n-substituidos com cicloalquilo e policicloalquilo, alfa-substituidos com arilo e heteroarilo e de composicoes farmaceuticas que os contem PT98842B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57662890A 1990-08-31 1990-08-31
US72665591A 1991-07-12 1991-07-12

Publications (2)

Publication Number Publication Date
PT98842A true PT98842A (pt) 1992-08-31
PT98842B PT98842B (pt) 1999-01-29

Family

ID=27077012

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98842A PT98842B (pt) 1990-08-31 1991-08-30 Processo para a preparacao de derivados de fenilalanina e de fenetilamina n-substituidos com cicloalquilo e policicloalquilo, alfa-substituidos com arilo e heteroarilo e de composicoes farmaceuticas que os contem

Country Status (9)

Country Link
EP (1) EP0547178A4 (pt)
JP (1) JPH06502627A (pt)
KR (1) KR100222634B1 (pt)
CA (1) CA2088195A1 (pt)
IE (1) IE67290B1 (pt)
NO (1) NO312298B1 (pt)
NZ (1) NZ239595A (pt)
PT (1) PT98842B (pt)
WO (1) WO1992004045A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217957A (en) * 1991-08-20 1993-06-08 Warner-Lambert Company Cholecystokinin antagonists useful for treating depression
US5380872A (en) * 1992-07-14 1995-01-10 Glaxo Inc. Modulators of cholecystokinin
WO1994018229A1 (en) * 1993-02-03 1994-08-18 Fisons Corporation 1,2,4-triazinone derivatives and their use in therapy
GB9304500D0 (en) * 1993-03-05 1993-04-21 Glaxo Spa Heterocyclic compounds
EP0920424B1 (en) 1996-08-22 2005-11-30 Warner-Lambert Company Llc Non-peptide bombesin receptor antagonists
US6645968B2 (en) 1999-08-03 2003-11-11 Abbott Laboratories Potassium channel openers
US6846836B2 (en) 2003-04-18 2005-01-25 Bristol-Myers Squibb Company N-substituted phenylurea inhibitors of mitochondrial F1F0 ATP hydrolase
DK2384753T3 (en) 2003-08-29 2016-04-11 Brigham & Womens Hospital Hydantoin derivatives as inhibitors of cell necrosis
EP2066329B1 (en) 2006-09-15 2017-09-06 Reviva Pharmaceuticals, Inc. Synthesis, methods of using, and compositions of cyclobutylmethylamines
BRPI0923126A2 (pt) 2008-12-23 2021-09-08 President And Fellows Of Harvard College Compostos inibidores de molécula pequena de necroptose, uso e composição compreendendo os mesmos e método de diminuir necroptose
GB0919194D0 (en) 2009-11-02 2009-12-16 Lytix Biopharma As Compounds
WO2012003501A2 (en) 2010-07-02 2012-01-05 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
EP2968276A4 (en) 2013-03-15 2017-02-15 President and Fellows of Harvard College Hybrid necroptosis inhibitors
WO2016094846A1 (en) 2014-12-11 2016-06-16 President And Fellows Of Harvard College Inhibitors of cellular necrosis and related methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757151A (en) * 1985-11-14 1988-07-12 Warner-Lambert Company 2-substituted-[2-substituted-amino]-N-arylalkyl-3-[indol-3-yl]
CA1291031C (en) * 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
US4814463A (en) * 1985-12-31 1989-03-21 Biomeasure, Inc. CCK antagonists
FR2606963B1 (fr) * 1986-11-14 1989-01-13 Cit Alcatel Boitier de repeteur sous-marin
JPH03503650A (ja) * 1988-04-05 1991-08-15 アボツト・ラボラトリーズ Ｃｃｋアンタゴニストとしてのトリプトファン誘導体
NZ234264A (en) * 1989-06-29 1993-05-26 Warner Lambert Co N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives, and pharmaceutical compositions
US5244915A (en) * 1990-08-31 1993-09-14 Warner-Lambert Company Amico acid derivatives cyclized at the c-terminal

Also Published As

Publication number Publication date
JPH06502627A (ja) 1994-03-24
NZ239595A (en) 1994-06-27
KR930703349A (ko) 1993-11-29
EP0547178A1 (en) 1993-06-23
NO930709L (no) 1993-04-15
KR100222634B1 (ko) 1999-10-01
WO1992004045A1 (en) 1992-03-19
NO312298B1 (no) 2002-04-22
AU651390B2 (en) 1994-07-21
PT98842B (pt) 1999-01-29
AU8749291A (en) 1992-03-30
CA2088195A1 (en) 1992-03-01
EP0547178A4 (en) 1994-07-06
IE913077A1 (en) 1992-03-11
NO930709D0 (no) 1993-02-26
IE67290B1 (en) 1996-03-20

Similar Documents

Publication Publication Date Title
PT99671A (pt) Processo para a preparacao de heparosanos-n,o-sulfatados e de composicoes farmaceuticas que os contem
PT99227A (pt) Processo para a preparacao de derivados da quinazolina e de composicoes farmaceuticas que os contem
PT98369A (pt) Processo para a preparacao de azois substituidos e de composicoes farmaceuticas que os contem
PT93094A (pt) Processo para a preparacao de 1,3-oxatiolanos substituidos e de composicoes farmaceuticas que os contem
PT90662A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados arilmetilenilicos de tiazolidinonas, imidazolidinonas e oxazolidinonas uteis como agentes antialergicos e agentes antiinflamatorios
PT92497A (pt) Processo para a preparacao de derivados de ureia de dipeptideos inibidores de enzimas, e de composicoes farmaceuticas que os contem
BR1100850A (pt) Composto, processo para a preparação de um composto, e, composição farmacêutica
PT98529A (pt) Processo para a preparacao de derivados de acetamida e de composicoes farmaceuticas que os contem
PT89497A (pt) Processo para a preparacao de compostos piperidinilicos 1,4-dissubstituidos e de composicoes farmaceuticas que os contem
BR9103036A (pt) Composto,formulacao farmaceutica e processo para a preparacao do composto
PT97114A (pt) Processo para a preparacao de derivados de hidantoina e de composicoes farmaceuticas que os contem
PT98365A (pt) Processo para a preparacao de novos derivados de oxalilo e de composicoes farmaceuticas que os contem
MX9205155A (es) Derivados heterociclicos n-substituidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
PT91701A (pt) Processo para a preparacao de esteres nitrato organicos e de composicoes farmaceuticas que os contem, tendo actividade relaxante
PT93067A (pt) Processo para a preparacao de derivados de 2-hidroxiacidos alifaticos e de eteres de 1-benzil-3-hidroximetilindazol, e de composicoes farmaceuticas que os contem
PT90017A (pt) Processo para a preparacao de derivados de arilpiperazinilalcoxi de imidas ciclicas e de uma composicao farmaceutica que os contem
PT89486A (pt) Processo para a preparacao de derivados 16-de-hidro de vitamina d3 e de composicoes farmaceuticas que os contem
PT90563A (pt) Processo para a preparacao de 3-(n-meterociclil)-2,6-diaminopiridinas e de -n-oxidos substituidos e de composicoes farmaceuticas que os contem
PT89715A (pt) Processo para a preparacao de novos derivados de 1,4-benzoxazina e 1,4-benzotiazina e de composicoes farmaceuticas que os contem
PT94629A (pt) Processo para a preparacao de derivados de cromado e de composicoes farmaceuticas que os contem
PT93290A (pt) Processo para a preparacao de novos eteres heterociclicos e de composicoes farmaceuticas que os contem
PT88351A (pt) Processo para a preparacao de derivados de isoxazol-beta-carbolina e de composicoes farmaceuticas que os contem
PT96154A (pt) Processo para a preparacao de derivados de carbamoilo e de composicoes farmaceuticas que os contem
PT90841A (pt) Processo para a preparacao de derivados de pirol e de composicoes farmaceuticas que os contem
PT89182A (pt) Processo para a preparacao de derivados de 3-hidroxi-2-(4-metoxi-fenil)-5-(2-metilamino-etil)-2,3-dihidro-5h-1,5-benzotiazepina-4-ona e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920424

FG3A Patent granted, date of granting

Effective date: 19981030

MM3A Annulment or lapse

Effective date: 20060502